BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Anti-D and Anti-c Antibody Quantification
NHS Blood & Transplant (NHSBT) Red Cell Immunohaematology (RCI) function is seeking to provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. Antibody (anti-D and anti-c) quantification is a vital component of RCI service, predominantly providing service to NHS hospitals. The test results play a crucial role in guiding the clinical management of alloimmunised ANC patients’ by predicting the risk of haemolytic disease of the foetus and newborn and triggering referral to an FMU specialist, In addition, quantification is used to assist in the laboratory differentiation of immune anti-D from passive anti-D Ig. The test is vital for identifying levels of alloimmune and prophylactic anti-D, as well as alloimmune anti-c in obstetric and other referrals.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| White Horse Scientific ltd | 07412261 | £4,360,092 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 | £2,180,046 initial term | White Horse Scientific ltd | active |
Government spending data: This supplier has received £146,546 in 8 payments (over £25k) from London Ambulance Service NHS Trust, Guy's and St Thomas' NHS FT (2020-12-18 to 2025-02-03). View full payment history →